- Home
- VEON vs OGN Comparison
VEON vs OGN Comparison
Compare VEON & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEON
- OGN
- Stock Information
- Founded
- VEON 1992
- OGN 1923
- Country
- VEON United Arab Emirates
- OGN United States
- Employees
- VEON N/A
- OGN N/A
- Industry
- VEON Telecommunications Equipment
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- VEON Telecommunications
- OGN Health Care
- Exchange
- VEON Nasdaq
- OGN Nasdaq
- Market Cap
- VEON 2.7B
- OGN 2.5B
- IPO Year
- VEON 1996
- OGN N/A
- Fundamental
- Price
- VEON $51.25
- OGN $9.52
- Analyst Decision
- VEON Strong Buy
- OGN Hold
- Analyst Count
- VEON 1
- OGN 4
- Target Price
- VEON $60.00
- OGN $18.00
- AVG Volume (30 Days)
- VEON 231.2K
- OGN 3.5M
- Earning Date
- VEON 08-07-2025
- OGN 08-05-2025
- Dividend Yield
- VEON N/A
- OGN 0.85%
- EPS Growth
- VEON N/A
- OGN N/A
- EPS
- VEON 6.56
- OGN 2.88
- Revenue
- VEON $4,088,000,000.00
- OGN $6,294,000,000.00
- Revenue This Year
- VEON $7.32
- OGN N/A
- Revenue Next Year
- VEON $6.68
- OGN $1.11
- P/E Ratio
- VEON $7.73
- OGN $3.29
- Revenue Growth
- VEON 8.84
- OGN N/A
- 52 Week Low
- VEON $25.92
- OGN $8.01
- 52 Week High
- VEON $59.68
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- VEON 60.91
- OGN 44.17
- Support Level
- VEON $50.55
- OGN $9.53
- Resistance Level
- VEON $54.65
- OGN $10.27
- Average True Range (ATR)
- VEON 2.45
- OGN 0.34
- MACD
- VEON 1.05
- OGN -0.04
- Stochastic Oscillator
- VEON 54.90
- OGN 5.49
About VEON VEON Ltd. ADS
VEON Ltd is a United Arab Emirates-based digital operator providing connectivity and Internet services to corporations and individuals. The company offers mobile and fixed-line telecommunications services through a range of traditional and broadband mobile technologies. The company's reportable segments consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. It provides its services under the Beeline, Kyivstar, Banglalink, and Jazz brands. It generates the majority of its revenue from Pakistan.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.